Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
NSAID; COX-1/2 inhibitor.
c-Raf, RET, VEGFR1 inhibitor, potential HMT inh...
Reduces production of thyroid hormones
Microtubule depolymerization inhibitor.
Ras inhibitor.
Fluoroquinolone, optically active isomer of ofl...
Isoflavone daidzein derivative found in Puerari...
Triadimefon metabolite; mutagen.
HIV protease inhibitor.
ALK4/5/7 (activin-like) inhibitor, TGF-β inhib...
Diterpene found in Taxus; potential microtubule...
mAChR agonist, selective for M2.
ROCK1/2 inhibitor, potential RSK and p70S6K inh...
Mixture of oligomycins A, B, C; oxidative phosp...
VEGFR, PDGFR, c-Kit inhibitor.
Endogenous peptide hormone, involved in intesti...
Catalyzes hydrolysis of asparagine.
Antimicrobial peptide found in amphibians.
Anti-diabetic alkaloid
COMT inhibitor.